PUBLISHER: Blueweave Consulting | PRODUCT CODE: 1301806
PUBLISHER: Blueweave Consulting | PRODUCT CODE: 1301806
India in-vitro fertilization (IVF) services market is flourishing because of an increasing supportive government initiatives & funding and increasing awareness and acceptance of IVF services.
BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated India in-vitro fertilization (IVF) services market size at USD 915.83 million in 2022. During the forecast period between 2023 and 2029, BlueWeave expects India in-vitro fertilization (IVF) services market size to expand at a robust CAGR of 16.53% reaching a value of USD 2,652.9 million by 2029. Major growth drivers for the India in-vitro fertilization (IVF) services market include an increasing prevalence of delayed pregnancies, growing infertility cases, rising advancements in assisted reproductive technology (ART), surging IVF success rates, and high disposable income. Also, growing awareness about IVF treatments, coupled with changing societal attitudes towards infertility, has reduced the stigma associated with seeking assistance. This has led to a greater acceptance of IVF services and an increase in the number of individuals and couples opting for such treatments. Government initiatives, such as the provision of financial support and the implementation of regulations to ensure the safety and quality of IVF services, also play a significant role in driving the market forward. Notably, the prevalence of infertility rises due to an increase in various risk factors, including obesity, stress, polycystic ovarian syndrome (PCOS), sexually transmitted infections, endometrial tuberculosis, and other medical conditions. The expanding occurrence of these factors contributes to the growing demand for infertility treatments, creating a favorable market landscape during the forecast period. However, high cost of IVF treatments and lack of insurance coverage are anticipated to restrain the overall market growth during the period in analysis.
In vitro fertilization (IVF) is a widely practiced laboratory-based treatment for infertility. This assisted reproductive technology involves the extraction of one or more eggs from the ovaries, which are then fertilized by sperm in a controlled environment outside the body. It is a prominent fertility treatment within the clinical field. The IVF process encompasses several stages, including ovarian stimulation, egg retrieval, fertilization through insemination, embryo culture, and ultimately, the transfer of the developed embryo into the uterus. The duration of the treatment spans several months. In cases where natural methods have been unsuccessful, IVF offers an alternative approach to achieving conception.
COVID-19 pandemic adversely affected India in-vitro fertilization (IVF) services market. Lockdown measures and disruptions in healthcare services had a temporary impact on the accessibility and availability of IVF treatments in India. Many clinics suspended or limited their operations, resulting in a decline in the number of treatment cycles. Travel restrictions and financial uncertainties also led some individuals and couples to postpone their fertility plans. However, as restrictions eased and safety protocols were implemented, the market began showing signs of recovery. The pandemic underscored the significance of maintaining strong healthcare systems and ensuring the uninterrupted provision of reproductive healthcare services during challenging times.
Based on cycle type, the India in-vitro fertilization (IVF) services market is divided into Fresh IVF Cycles, Thawed IVF Cycles, and Donor Egg IVF Cycles segments. The fresh IVF cycles segment holds the highest share in the India in-vitro fertilization (IVF) services market. The fresh IVF cycles offer higher success rates compared to frozen cycles, as fresh embryos have better implantation potential. The fresh cycles allow for a more personalized approach, as the treatment plan can be tailored according to the patient's specific needs and response to stimulation. Also, fresh cycles provide a higher chance of obtaining multiple embryos, which increases the possibility of having surplus embryos for future use. Meanwhile, the thawed IVF cycles segment is expected to witness fastest growth rate during the forecast period due to advancements in cryopreservation techniques, improved success rates of frozen embryo transfers, and the convenience it offers in terms of scheduling and treatment planning for patients.
Major players operating in the India in-vitro fertilization services market include: ART Fertility Clinics, Bavishi Fertility Institute, Craft Hospital & Research Centre, Dr. Thomas Fertility Center/Chennai Fertility Centers, Gunasheela Hospital, Iswarya Fertility Center, Lifeline Hospitals, Nova IVI Fertility, and Oasis Centre. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.
The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of India In-Vitro Fertilization Services (IVF) Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in India In-Vitro Fertilization (IVF) Services Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.
*Financial information in case of non-listed companies will be provided as per availability
**The segmentation and the companies are subjected to modifications based on in-depth secondary for the final deliverable